Observations placeholder
Mebeverine
Identifier
005412
Type of Spiritual Experience
Background
A description of the experience
Mebeverine [3] is a musculotropic antispasmodic drug without atropic side-effects whose major therapeutic role is in the treatment of irritable bowel syndrome. It is also indicated for treatment of gastrointestinal spasm secondary to organic disorder. It was first registered in 1965. It is manufactured and marketed as Colofac, Duspatal and Duspatalin. It too is anticholinergic and blocks muscarinic receptors
On Aug, 11, 2015: 224 people reported to have side effects when taking Mebeverine hydrochloride. Among them, 4 people (1.79%) have Hallucination.
On Jan, 18, 2017 284 people reported to have side effects when taking Duspatal. Among them, 4 people (1.41%) have Hallucination